Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections

Lorena Martin-Jaular1, Ernesto S Nakayasu, Mireia Ferrer

  • 1Poverty-Related Diseases, Barcelona Centre for International Health Research, Barcelona, Spain.

Plos One
|November 3, 2011
PubMed

Insights

Reticulocyte-derived exosomes carrying Plasmodium yoelii antigens can elicit immune responses. Immunization with these exosomes and CpG adjuvant significantly improved survival and parasite clearance in mice challenged with malaria.

Area of Science:

  • Immunology
  • Parasitology
  • Cell Biology

Background:

  • Exosomes are small vesicles involved in intercellular communication.
  • Initially thought to be involved in waste removal, exosomes are now known to play roles in antigen presentation.
  • Malaria, caused by Plasmodium parasites, remains a significant global health challenge.

Purpose of the Study:

  • To investigate the potential of exosomes derived from Plasmodium yoelii-infected reticulocytes as a vaccine candidate.
  • To characterize the immune response elicited by these exosomes.

Main Methods:

  • Isolation and proteomic analysis of exosomes from infected mouse blood and reticulocyte cultures.
  • Immunization of mice with purified exosomes, with and without CpG adjuvant.
  • Assessment of antibody responses (IgG, IgG2a, IgG2b) and protection against lethal Plasmodium yoelii challenge.

Main Results:

  • Exosomes from infected mice contained Plasmodium yoelii proteins.
  • Immunization with these exosomes induced antibodies recognizing infected red blood cells.
  • Exosome immunization significantly reduced parasitemia, increased survival, and altered parasite tropism.
  • Adjuvant inclusion enhanced antibody production and led to sterile protection in 83% of challenged animals.

Conclusions:

  • Reticulocyte-derived exosomes can carry parasite antigens and modulate immune responses.
  • Exosomes represent a novel platform for developing anti-malarial vaccines.
  • This study opens new avenues for malaria immunotherapy.